To access this element change to forms mode OFF
Grant Award View - GA82107
Colchicine After Stroke to Prevent Event Recurrence (CASPER) Study
GA ID:
GA82107
Agency:
Department of Health and Aged Care
Approval Date:
14-May-2020
Publish Date:
11-Jun-2020
Category:
Health and Medical Research
Grant Term:
1-Jun-2020 to 31-May-2023
Value (AUD):
$2,997,908.45
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 19/20 1.1 Health Policy Research and Analysis
Grant Program:
2019_MRFF_Cardiovascular_Health_2020
Grant Activity:
Colchicine After Stroke to Prevent Event Recurrence (CASPER) Study
Purpose:
Inflammation plays a critical role in the rupture of artery plaques, leading to acute stroke. Despite current best treatments, many people remain at high risk of recurrent stroke events, predominantly because current therapies do not specifically target the inflammatory component of arterial disease. This project investigates the ability of colchicine, a safe and commonly used anti-inflammatory drug, to inhibit vascular disease-associated inflammation, thereby improving clinical outcomes.
GO ID:
GO Title:
MRFF - Cardiovascular Health Mission - 2019 Cardiovascular Health Grant Opportunity
Internal Reference ID:
MRF1201196
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA